CH620679A5 - - Google Patents

Download PDF

Info

Publication number
CH620679A5
CH620679A5 CH540977A CH540977A CH620679A5 CH 620679 A5 CH620679 A5 CH 620679A5 CH 540977 A CH540977 A CH 540977A CH 540977 A CH540977 A CH 540977A CH 620679 A5 CH620679 A5 CH 620679A5
Authority
CH
Switzerland
Prior art keywords
radical
general formula
amino
lower alkyl
phenyl
Prior art date
Application number
CH540977A
Other languages
English (en)
French (fr)
Inventor
Michel Vincent
Georges Remond
Michel Laubie
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of CH620679A5 publication Critical patent/CH620679A5/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH540977A 1976-04-29 1977-04-29 CH620679A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7612671A FR2361880A1 (fr) 1976-04-29 1976-04-29 Nouvelles 4-amino piperidines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (1)

Publication Number Publication Date
CH620679A5 true CH620679A5 (es) 1980-12-15

Family

ID=9172434

Family Applications (1)

Application Number Title Priority Date Filing Date
CH540977A CH620679A5 (es) 1976-04-29 1977-04-29

Country Status (12)

Country Link
US (1) US4246267A (es)
JP (2) JPS52133989A (es)
AT (1) AT361924B (es)
AU (1) AU508575B2 (es)
BE (1) BE854072A (es)
CH (1) CH620679A5 (es)
DE (1) DE2719211C3 (es)
ES (1) ES458307A1 (es)
FR (1) FR2361880A1 (es)
GB (1) GB1544191A (es)
IL (1) IL51966A (es)
NL (1) NL7704760A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
GR1000662B (el) * 1988-07-01 1992-09-25 Janssen Pharmaceutica Nv Μεθοδος παρασκευης cis-ν-(3-μεθοξυ-4-πιπεριδινυλο)βενζαμιδιων.
US5106983A (en) * 1990-04-30 1992-04-21 The United States Of America As Represented By The Secretary Of The Army Process of making carfentanil and related analgesics
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5466691A (en) * 1991-08-09 1995-11-14 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compound
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0103818D0 (sv) * 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
WO2005123679A2 (en) * 2004-06-18 2005-12-29 Neurosearch A/S Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CN113214139B (zh) * 2020-02-03 2022-03-04 江苏谛奇医药科技有限公司 哌啶酰胺类衍生物及其制备方法、其药物组合物、其单晶培养方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2846437A (en) * 1955-09-12 1958-08-05 Sterling Drug Inc Lower alkyl 4-phenyl-1-(substituted-alkyl) piperidine-4-carboxylates and preparationthereof
US3479346A (en) * 1961-08-08 1969-11-18 Sterling Drug Inc N-acyl-n- (and n,n-bis-) ((1-piperidyl)-lower-alkyl)amines
US3218327A (en) * 1963-10-02 1965-11-16 Parke Davis & Co alpha-naphthylamine alkyl piperidine compounds
US3869463A (en) * 1973-01-17 1975-03-04 Wyeth John & Brother Ltd N-phenyl derivatives of alkanoylamido piperidines

Also Published As

Publication number Publication date
IL51966A0 (en) 1977-06-30
FR2361880B1 (es) 1978-12-15
NL7704760A (nl) 1977-11-01
ATA306177A (de) 1980-09-15
FR2361880A1 (fr) 1978-03-17
JPS52133989A (en) 1977-11-09
AU2464877A (en) 1978-11-02
BE854072A (fr) 1977-10-28
AT361924B (de) 1981-04-10
AU508575B2 (en) 1980-03-27
JPS549282A (en) 1979-01-24
US4246267A (en) 1981-01-20
DE2719211C3 (de) 1982-01-07
GB1544191A (en) 1979-04-11
IL51966A (en) 1981-01-30
DE2719211A1 (de) 1977-11-03
ES458307A1 (es) 1978-02-16
DE2719211B2 (de) 1980-10-09

Similar Documents

Publication Publication Date Title
CA2552565C (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
EP0591057A1 (fr) Arylalkyl(thio)amides ayant une affinité sélective pour les récepteurs de la mélatonine et leur procédé de préparation
CH620679A5 (es)
EP0041410B1 (fr) Nouveaux éthers tricycliques, leurs procédés de préparation et leur utilisation comme médicament
EP0486386A2 (fr) Nouveaux dérivés de la N-benzoyl proline, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0109866B1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP1525188B1 (fr) Derives de 4,4 -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
EP0520016B1 (fr) Derives de l'uree, leur preparation et les medicaments les contenant
EP0397556A1 (fr) N-Phényl amides, leurs procédés de préparation et les médicaments les contenant
EP0004494A1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
CH625214A5 (es)
EP0138684B1 (fr) 2-(N-pyrrolidino)-3-isobutoxy-N-phenyl substitué N-benzyl propylamines, leur préparation et leur application pharmaceutique
CA1076117A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant
EP0259206A1 (fr) Dérivés de la dihydro-1,4 pyridine leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
BE890948A (fr) Derives de l'acide anthranilique
EP0119107A1 (fr) Nouveaux dérivés du bicyclo(4.2.0)octatriène-1,3,5, leur préparation et leur application en thérapeutique
LU85780A1 (fr) Nouveaux esters enoliques precurseurs de medicaments et composition pharmaceutique les contenant
EP1177169A1 (fr) Derives de 6- [(aryl et heteroaryl) oxy]methyl] n aphtalene-2- carboximidamide, leur preparation et leur application en therapeutique
EP0158545B1 (fr) Dérivés d'acide [alpha-(alkylaminométhyl)-benzylthio]-acétique, procédé de préparation et utilisation en thérapeutique
EP0105881B1 (fr) Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
EP0061406B1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
EP0103500B1 (fr) Dérivés de phénéthyl-1alpha-phényl-pipéridine-3-propanenitrile, leur préparation et leur application en thérapeutique
CH624389A5 (en) Process for the preparation of new methylamine derivatives
FR2526793A1 (fr) Nouveaux a-(n-pyrrolyl)-acides et leurs sels et esters, utiles comme medicaments et procede de la preparation de tels composes
CA1095039A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant

Legal Events

Date Code Title Description
PL Patent ceased